Atrial Fibrillation (AF) Clinical Trials in Atlanta, Georgia

6 studies are recruiting for atrial fibrillation (af) in Atlanta, Georgia right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable

   This study is researching 2 different experimental drugs called REGN7508 and REGN9933 (called "study drugs"). The study is focused on people who have atrial fibrillation, which means that the heart beats too fast and unevenly. When this happens, blood cannot move smoothly through the heart; it can …

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Atlanta Clinical Research Centers, Atlanta, Georgia

   Locations

   35 in total

   Run by

   Regeneron Pharmaceuticals

   See if you can join NCT07430956 on ClinicalTrials.gov

2. Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation

   This study is researching an experimental drug called REGN7508 (called "study drug") and how it compares against another treatment called apixaban. The study is focused on people who have atrial fibrillation, which means that the heart beats too fast and unevenly. The aim of the study is to see how…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Atlanta Clinical Research Centers, Atlanta, Georgia

   Locations

   32 in total

   Run by

   Regeneron Pharmaceuticals

   See if you can join NCT07626411 on ClinicalTrials.gov

3. Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation

   This study is researching experimental drugs called REGN7508 and REGN9933. The study is focused on participants who have atrial fibrillation, which means that the heart beats too fast and unevenly. REGN7508 and REGN9933 are designed to help stop blood clots forming in patients with atrial fibrillat…

   Stage

   Phase 2

   Ages

   18 and older

   Site

   Grady Health System, Atlanta, Georgia

   Locations

   81 in total

   Run by

   Regeneron Pharmaceuticals

   See if you can join NCT07175428 on ClinicalTrials.gov

4. Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)

   Conquer-AF is a prospective, multi-center, interventional, non-randomized clinical study that will enroll up to 400 subjects at up to 30 sites across the United States, Europe, and Australia. Subjects diagnosed with symptomatic recurrent paroxysmal or persistent atrial fibrillation after a single p…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Piedmont Heart Institute, Atlanta, Georgia

   Locations

   30 in total

   Run by

   Medtronic Cardiac Ablation Solutions

   See if you can join NCT07298473 on ClinicalTrials.gov

5. Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation

   To evaluate the safety and effectiveness of the Argá Medtech CSE Ablation System in the treatment of atrial fibrillation.

   Stage

   Not phased

   Ages

   18 to 80

   Site

   Emory, Atlanta, Georgia

   Locations

   27 in total

   Run by

   Arga Medtech SA

   See if you can join NCT06784466 on ClinicalTrials.gov

6. Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Drivers of AF Study

   The goal of this clinical trial is to compare the use of the Vektor Computational ECG Mapping System (vMap®) with pulmonary vein isolation (PVI), to using PVI alone, to treat Atrial Fibrillation (AF) in adults. Participants will have a 50/50 or 1 out of 2 chance of being placed in the treatment or …

   Stage

   Not phased

   Ages

   22 and older

   Site

   Piedmont Heart Institute, Atlanta, Georgia

   Locations

   13 in total

   Run by

   Vektor Medical

   See if you can join NCT06935591 on ClinicalTrials.gov